Skip to main content
. 2016 Mar 1;10(3):QC17–QC20. doi: 10.7860/JCDR/2016/17839.7438

[Table/Fig-2]:

Patients with/without metabolic syndrome.

Parameters MS (N=33) Non-MS (N= 31) p-value
Age (y) 54 (11) 50 (09) 0.012
Height (m)^ 1.51 (0.06) 1.50 (0.05) 0.627
Weight (kg)^ 66 (13) 58 (11) 0.013
BMI (kg/m2) 29 (07) 24 (07) 0.018
Overweight/Obese (BMI ≥23.0 kg/m2) * 28 (85%) 19 (61%) 0.0001
WC (cm)^ 101 (13) 94 (12) 0.040
Central Obesity (WC ≥ 80 cm)* 29 (87%) 23 (69%) 0.0001
SBP (mm Hg) 130 (23) 120 (21) 0.010
DBP (mm Hg) 87 (10) 80 (10) 0.002
Post-menopausal status (yrs) 08 (11) 04 (07) 0.050
Total Cholesterol (mmol/l)^ 4.94 (0.98) 5.02 (1.21) 0.840
Triglyceride (mmol/l) 1.70 (0.75) 1.24 (0.53) 0.024
HDL Cholesterol (mmol/l) 1.08 (0.20) 1.34 (0.36) 0.001
LDL Cholesterol (mmol/l) 2.72 (0.69) 2.72 (1.06) 0.973
VLDL Cholesterol (mmol/l) 0.77 (0.38) 0.57 (0.26) 0.039
FPG (mmol/l) 5.83 (02) 5.16 (0.66) 0.002
25-OH Vitamin D (nmol/l) 52.5 (47.5) 45 (47.5) 0.904
Vitamin D deficiency* (serum 25-OH vitamin D < 50 nmol/l) 16 (48%) 17 (55%) 0.16

BMI-body mass index; WC- waist circumference; SBP-systolic blood pressure; DBP-diastolic blood pressure; HDL- high density lipoprotein; LDL- low density lipoprotein; VLDL – very low density lipoprotein; FPG – fasting plasma glucose.

*Expressed as number with percentages

^Expressed as mean with standard deviation

Rest parameters are expressed as median with inter-quartile range.